MD Anderson and Broad Institute launch new translational research platform focused on rare cancers
Joint initiative will develop comprehensive collection of molecularly and functionally characterized rare cancer tumor models to inform novel therapeutic strategies

Credit: Susanna M. Hamilton, Broad Communications